Coronavirus vaccine makers led gains in healthcare stocks last year. And the trend didn't stop as the world rang in the new year. Many of these companies charged full speed ahead into 2021. And for good reason. Some of them began generating revenue from vaccines. Others moved closer to bringing a potential vaccine to market.

But recently, excitement around some of the biggest winners has started to fade. Now, the big question is whether share price declines represent a buying opportunity -- or a sign to flee the stock. Let's take a look at three of the biggest movers.

Vaxart (NASDAQ:VXRT) skyrocketed more than 300% from the start of the year through Feb. 2. That's after last year's 1,500% gain. The biotech company is developing an oral COVID-19 vaccine. That potential product could be a game changer. Imagine a vaccine without a jab -- and the ease of transporting and storing a room-temperature-stable tablet.

More in category

Opinion: Hydrogen is the one clean energy source everyone seems to like, so why aren’t we using it more to fight climate change?
April 22, 2021MarketWatch
Opinion: Hydrogen is the one clean energy source everyone seems to like, so why aren’t we using it more to fight climate change?
Mortgage rates drop below 3% again — offering opportunities to buyers and homeowners
April 22, 2021MarketWatch
Mortgage rates drop below 3% again — offering opportunities to buyers and homeowners
‘Sales have a good deal further to fall’: Property prices see record growth, but existing-home sales decline
April 22, 2021MarketWatch
‘Sales have a good deal further to fall’: Property prices see record growth, but existing-home sales decline
‘Massive helicopter drop of money’ from Fed and Washington raises inflation risk, says manager of $88 billion bond fund
April 22, 2021MarketWatch
‘Massive helicopter drop of money’ from Fed and Washington raises inflation risk, says manager of $88 billion bond fund
Opinion: With SPACs down as much as 90%, there are finally some good buys
April 21, 2021MarketWatch
Opinion: With SPACs down as much as 90%, there are finally some good buys
Here are the biggest risks to oil’s rally
April 22, 2021MarketWatch
Here are the biggest risks to oil’s rally
Oregon: CDC investigating woman’s death after J&J vaccine
April 22, 2021MarketWatch
Oregon: CDC investigating woman’s death after J&J vaccine
Opinion: Intel’s new CEO has another big problem to fix
April 22, 2021MarketWatch
Opinion: Intel’s new CEO has another big problem to fix
Should I invest an IRA in bitcoin? How do I roll over old assets? These financial pros answer our retirement questions
April 22, 2021MarketWatch
Should I invest an IRA in bitcoin? How do I roll over old assets? These financial pros answer our retirement questions
Biden has pledged to tax the rich — but precisely how will he do that? Experts consider his options
April 22, 2021MarketWatch
Biden has pledged to tax the rich — but precisely how will he do that? Experts consider his options
My coworker wants to sell her house as prices have skyrocketed. The co-signer on her mortgage demands 25%. Can she sell without his permission?
April 22, 2021MarketWatch
My coworker wants to sell her house as prices have skyrocketed. The co-signer on her mortgage demands 25%. Can she sell without his permission?
Zombies, robots and big unknowns lurk as the U.S. economy recovers from pandemic
April 22, 2021MarketWatch
Zombies, robots and big unknowns lurk as the U.S. economy recovers from pandemic
Opinion: Warren Buffett could teach traders in dogecoin, GameStop and other hot trends a few things about ‘Mr. Market’
April 22, 2021MarketWatch
Opinion: Warren Buffett could teach traders in dogecoin, GameStop and other hot trends a few things about ‘Mr. Market’
Credit Suisse executives were grilled on Archegos losses. Here’s what they said
April 22, 2021MarketWatch
Credit Suisse executives were grilled on Archegos losses. Here’s what they said
Invest in electric-vehicle batteries, water tech and crypto applications to ride the green wave, says UBS
April 21, 2021MarketWatch
Invest in electric-vehicle batteries, water tech and crypto applications to ride the green wave, says UBS
Bitcoin bears are stalking crypto prices — here’s how low they could go
April 21, 2021MarketWatch
Bitcoin bears are stalking crypto prices — here’s how low they could go
Dogecoin army’s campaign to drive crypto to $1 was a bust — so why are the bulls feeling vindicated?
April 21, 2021MarketWatch
Dogecoin army’s campaign to drive crypto to $1 was a bust — so why are the bulls feeling vindicated?
Biden pledges to cut U.S. greenhouse gases 50% by 2030 — with major implications for oil and gas sector
April 20, 2021MarketWatch
Biden pledges to cut U.S. greenhouse gases 50% by 2030 — with major implications for oil and gas sector
‘The more we talk about it, the more we’re validating the symptoms’: What we know about COVID vaccine side effects in women
April 18, 2021MarketWatch
‘The more we talk about it, the more we’re validating the symptoms’: What we know about COVID vaccine side effects in women
WWE body slams Wall Street's forecasts
April 22, 2021FOX Business
WWE body slams Wall Street's forecasts
Bond traders betting on hotels or shopping malls now have Big Data at hand
April 22, 2021MarketWatch
Bond traders betting on hotels or shopping malls now have Big Data at hand